Every lot undergoes six independent assays before release. Results are published in the lot-specific Certificate of Analysis.
Every lot undergoes our 6-panel testing protocol: identification by ESI-MS, purification by RP-HPLC, conformity, sterility screening, quantification of net peptide content, and LAL endotoxin screening. Full analytical data is published in the Certificate of Analysis for each lot.
Lyophilized peptides should be stored at -20°C or below for long-term stability. Once reconstituted, peptides should be stored at 2–8°C and used within a reasonable timeframe depending on the specific compound. Avoid repeated freeze-thaw cycles. Always store in a dry environment away from direct light.
Orders are processed within 1–3 business days after payment confirmation. Orders placed after 3:00 PM Pacific time or on weekends and holidays will begin processing the next business day. We offer free standard shipping on orders over $150. All orders are shipped in insulated packaging with ice packs when necessary. Standard delivery typically takes 2–4 business days within the continental US.
No. All compounds sold by Genesis Peptides are strictly for in vitro and preclinical laboratory research purposes only. They are not approved for human consumption, therapeutic use, or diagnostic purposes. By purchasing, you confirm the products will be used solely for legitimate research applications.
A Certificate of Analysis (COA) is a document issued by our analytical laboratory that reports the results of all quality control tests performed on a specific lot of product. Each COA includes HPLC chromatograms, mass spectra, endotoxin results, and quantification data where applicable. COAs are available in our COA Library for every lot we have shipped.
Yes. We offer volume pricing for universities, research institutions, and laboratories with recurring needs. Discounts begin at 100+ units and scale with volume. Contact our team for a custom quote tailored to your research requirements.
FOR RESEARCH USE ONLY — Products are sold exclusively for in vitro and preclinical laboratory research. Not for human consumption or administration. Not intended for diagnostic or therapeutic use. These statements have not been evaluated by the FDA.

What is Melanotan I? Melanotan I, a synthetic analogue of α-MSH, acts as an agonist on melanocortin receptors, primarily MC1R [1]. This receptor plays an important role in normal skin pigmentation, found on the surface of skin pigment cells (melanocytes) [1]. Compared to Melanotan II, Melanotan I has a longer duration of action and is more resistant to enzymatic breakdown [2]. Because of its selectivity for MC1R, Melanotan I primarily influences skin pigmentation with minimal central nervous system penetration [2]. Melanotan I Effects & Benefits Tanning & Photoprotection Melanotan I stimulates tanning by binding to MC1R receptors in skin cells, increasing the production of eumelanin, the dark pigment that protects against UV damage [3]. This process enhances photoprotection. Conversely, those with mutations to this receptor produce more pheomelanin, tend to tan poorly, and have an increased risk for sunburn and skin cancer [4]. Melanotan I has been explored for photoprotection in those with these genetic conditions that heighten UV sensitivity [5]. Phase 1 studies have been conducted on Melanotan 1, in which participants received daily injections across 1-4 weeks and then exposed to limited UV-B or sunlight on specific parts of their skin [6]. Those who received the injections developed faster, darker tans than those exposed to light alone, which lasted three weeks longer and required less sun exposure to achieve. They also showed fewer sunburned skin cells, suggesting better skin protection. Neuroinflammation & Cognition Preliminary research has suggested that melanocortin activation may influence neuroprotective pathways in the brain through anti-inflammatory and neuroprotective actions. Animal studies show reductions in brain damage, improved recovery, and limited inflammation when given soon after a stroke [7]. A phase IIa clinical trial found that Melanotan I was safe and well-tolerated in patients who suffered strokes, with no serious side effects [7]. Most patients had improved brain scans and neurological recovery, suggesting a role in protecting brain tissue, stabilizing the blood-brain barrier, and supporting neuroplasticity even when administered up to 20 hours after stroke onset [7]. Blood Pressure & Vascular Health By mimicking the effects of α-MSH, Melanotan 1 may help support vascular health by improving endothelial function and nitric oxide production, which supports blood vessel relaxation [8]. Activation of MC1 receptors found on endothelial cells may enhance circulation, reduce stiffness, and protect against vascular dysfunction associated with metabolic stress [8]. However, current data is sparse. Unlike Melanotan II, it does not significantly activate central melanocortin receptors involved in autonomic control.

Melanotan II Effects & Benefits Melanotan II is a synthetic α-MSH analogue with the ability to bind MC1R, MC3R, MC4R, and MC5R receptors [R]. Compared to Melanotin I, it shows an ability to cross the blood-brain barrier, resulting in central nervous system effects including sexual behavior, appetite, and mood regulation. It has a shorter duration of action, Melanotan II Physiologic Effects Sexual Functions Melanotan II has documented effects on sexual arousal and erectile dysfunction because of its affinity for specific receptors in the brain [1]. By activating MC4R and MC3R, researchers found that it stimulated neural pathways involved in sexual motivation and performance, independent of direct sexual stimulation [1]. In animal studies, Melanotan II induced spontaneous erections and increased libido in both males and females [2, 3]. In a small study of men with psychological (not physical) erectile dysfunction, Melanotan-II triggered erections in most participants and kept them firm for much longer than a placebo [4]. Some men experienced mild side effects like nausea or yawning, but these were temporary and didn’t need treatment [4]. Pigmentation Melanotan analogs stimulate melanocytes to increase eumelanin production, leading to darker skin pigmentation [5]. While Melanotan I is highly selective for the MC1R receptor (which leads to more predictable tanning effects), Melanotan II activates multiple other receptors, which can cause broader systemic effects [6]. Appetite Regulation Melanotan II is thought to influence energy balance and appetite regulation via MC3R and MC4R activation in key regions of the brain that control hunger and satiety, the hypothalamus and nucleus accumbens [7]. In an animal study, researchers gave Melanotan II to rats and found that it caused a sharp drop in food intake over two days and significantly reduced body fat and insulin levels [8]. Even when combined with another brain chemical, neuropeptide Y, which normally increases hunger and fat storage, Melanotan II blocked most of these effects [8]. By acting on specific brain regions, melanotan II seems to reduce food intake, suppress appetite, and increase thermogenesis by activating brown adipose tissue [9]. Impulse Control and Addiction Emerging research has suggested that melanotan II may modulate dopamine and oxytocin pathways, potentially influencing reward processing, mood, and addiction-related behaviors [10]. One study in rats found that injecting melanotan II into the bloodstream was able to activate oxytocin-producing brain cells, a hormone linked to bonding and social behavior. While it did not directly cause oxytocin release inside the brain, it increased the activity of neurons and was able to increase blood levels, suggesting it may indirectly boost levels through brainstem pathways [11].

Snapshot MGF (IGF-1 Ec) is a specialized form of IGF-1 released after exercise or muscle strain to jump-start the body’s repair process. It helps activate muscle stem cells, supports recovery, and promotes healthy tissue rebuilding. Research also shows MGF may aid nerve protection and balanced immune responses, making it a key peptide for repair and resilience. What Is MGF (IGF-1) Ec? Mechano-growth factor (MGF), also known as IGF-1 Ec, MGF-E, and MGF Ec, is a 24-amino acid splice variant of the insulin-like growth factor-1 (IGF-1) gene that is uniquely expressed in response to mechanical loading, tissue strain, and muscular microdamage [1]. While classical IGF-1 isoforms (such as IGF-1 Ea, the most ubiquitous form) participate in endocrine and paracrine signaling related to growth, metabolism, and recovery, MGF represents a specialized version with distinct biological roles. The key difference lies in its E-domain sequence, which alters receptor binding dynamics and shifts its function toward local tissue repair rather than systemic growth signaling. Native IGF-1 promotes pathways like PI3K/Akt and mTOR, while MGF is believed to stimulate satellite cell activation, promoting local cellular proliferation and preparing damaged fibers for subsequent IGF-1–mediated differentiation [2]. Because of its rapid, short-lived expression following mechanical stress, endogenous MGF acts as the body’s immediate “alert” peptide for muscle and connective-tissue adaptation. MGF (IGF-1) Ec Mechanism of Action and Benefits Muscle Growth and Repair MGF (IGF-1 Ec) is most recognized for its involvement in the early stages of muscle repair, where it acts as a rapid-response signal following mechanical strain or localized microdamage. Unlike systemic IGF-1 isoforms that are involved in sustained anabolic activity, MGF initiates the activation and proliferation of satellite cells, the stem-like cells responsible for muscle regeneration. An in vitro study used primary human muscle cell cultures from donors of different ages (neonatal, young adult, old adult) to investigate the effects of MGF (IGF-1 Ec) on muscle regeneration pathways [3]. MGF (IGF-1 Ec) administration resulted in: Increased proliferative lifespan of satellite cells in neonatal and young adult cultures. Strong satellite cell activation and myogenic fusion, supporting enhanced muscle repair potential. Hypertrophy-like changes across all age groups, and a significant reduction in reserve satellite cells, indicating increased recruitment. The peptide substantially enhanced satellite cell activation, proliferation, and fusion, supporting improved muscle repair and maintenance. Because its effects are strongest in neonatal and young adult muscle, MGF (IGF-1 Ec) may represent a promising therapeutic strategy for preventing age-related sarcopenia. Neuroprotection and Neurogenesis Beyond its well-established role in muscular adaptation, MGF (IGF-1 Ec) has been investigated for its influence on neural resilience and regenerative signaling within the central and peripheral nervous systems. A preclinical in vivo/in vitro model of neuronal ischemia evaluated neuroprotective mechanisms of MGF (IGF-1 Ec) [4]. Results showed: Substantial protection to neurons typically highly vulnerable to ischemic injury, in the gerbil in vivo model. After ischemia, endogenous MGF expression increased in resistant hippocampal neurons, suggesting a natural protective role. MGF (IGF-1 Ec) peptide was as potent and longer lasting than full-length IGF-1 in preventing neurodegeneration. Neuroprotective effects of MGF (IGF-1 Ec) occurred independently of the IGF-1 receptor, indicating a novel mode of action. The MGF (IGF-1 Ec) peptide demonstrates potent, sustained neuroprotective effects in both in vivo and in vitro ischemia models. Its ability to act independently of the IGF-1 receptor makes this peptide a promising therapeutic candidate for stroke recovery. Immune Modulation and Tissue Repair MGF (IGF-1 Ec) also plays a meaningful role in coordinating immune activity, especially in environments where mechanical stress or localized injury triggers an inflammatory response. Because MGF is rapidly upregulated in damaged tissue, it acts as an early signaling cue that helps transition the microenvironment from acute inflammation toward controlled regeneration. An animal study investigated whether exogenous MGF can rescue impaired muscle regeneration in a mouse model of skeletal muscle contusion combined with macrophage depletion [5]. Mice underwent muscle contusion injury followed by macrophage depletion to model impaired regenerative conditions. After the injection of injured muscles with synthetic MGF (IGF-1 Ec), results showed: Substantially reduced fibrosis markers Reduced pro-inflammatory mediators (TNF-α, IFN-γ, IL-1β, and TGF-β) Reduced chemokine receptor expression, indicating suppression of inflammatory cell recruitment Reduced gp91phox, an oxidative stress marker Although MGF did not directly enhance muscle fiber regeneration lost due to macrophage depletion, it improved the detrimental effects of macrophage loss by modulating inflammation. 1 Schlegel, W., Raimann, A., Halbauer, D., Scharmer, D., Sagmeister, S., Wessner, B., et al. (2013) Insulin-like growth factor I (IGF-1) Ec/Mechano Growth factor--a splice variant of IGF-1 within the growth plate. PLoS One, Public Library of Science (PLoS) 8, e76133 2 Dai, Z., Wu, F., Yeung, E. W. and Li, Y. (2010) IGF-IEc expression, regulation and biological function in different tissues. Growth Horm. IGF Res., Elsevier BV 20, 275–281 3 Kandalla, P. K., Goldspink, G., Butler-Browne, G. and Mouly, V. (2011) Mechano Growth Factor E peptide (MGF-E), derived from an isoform of IGF-1, activates human muscle progenitor cells and induces an increase in their fusion potential at different ages. Mech. Ageing Dev. 132, 154–162 4 Dluzniewska, J., Sarnowska, A., Beresewicz, M., Johnson, I., Srai, S. K. S., Ramesh, B., et al. (2005) A strong neuroprotective effect of the autonomous C-terminal peptide of IGF-1 Ec (MGF) in brain ischemia. FASEB J., Wiley 19, 1896–1898 5 Liu, X., Zeng, Z., Zhao, L., Chen, P. and Xiao, W. (2019) Impaired skeletal muscle regeneration induced by macrophage depletion could be partly ameliorated by MGF injection. Front. Physiol., Frontiers Media SA 10, 601